A newly discovered human pneumovirus isolated from young children with respiratory tract disease

B G van den Hoogen1, J C de Jong, J Groen

  • 1Department of Virology, Erasmus Medical Center, Rotterdam, the Netherlands.

Nature Medicine
|June 1, 2001
PubMed

Insights

A novel paramyxovirus, human metapneumovirus (hMPV), was discovered in young children, causing respiratory illnesses similar to RSV. This common virus has circulated globally for at least 50 years.

Area of Science:

  • Virology
  • Pediatric Respiratory Infections

Background:

  • The Metapneumovirus genus previously contained only avian pneumovirus.
  • Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory illness.

Purpose of the Study:

  • To identify and characterize a novel paramyxovirus isolated from young children.
  • To determine the clinical significance and prevalence of this new virus.

Main Methods:

  • Virological analysis
  • Sequence homology and gene constellation analysis
  • Serological studies

Main Results:

  • A novel paramyxovirus, named human metapneumovirus (hMPV), was identified.
  • hMPV infection presents with symptoms ranging from upper respiratory tract disease to severe pneumonia.
  • Serological data indicate near-universal hMPV exposure in Dutch children by age five.
  • The virus has been circulating in humans for at least 50 years.

Conclusions:

  • Human metapneumovirus is a newly identified respiratory pathogen in children.
  • hMPV is a significant cause of respiratory illness in young children, similar to RSV.
  • Widespread hMPV circulation suggests a long history of human infection.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
55
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
47
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24